In an animal experiment, cytokine therapy with IL-2/anti-IL-2 monoclonal antibody complexes could attenuate the development and progression of atherosclerosis by increasing CD4+CD25+Foxp3+ regulatory T cells in apolipoprotein E-deficient mice (Dinh et al., 2012). This evidence concerns the gene FOXP3 and atherosclerosis.